Overview
Study to Examine the Effect of HKI-272 on Rhythms of the Heart (Cardiac Repolarization)
Status:
Completed
Completed
Trial end date:
2008-07-01
2008-07-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to determine whether HKI-272 affects the rhythms of the heart (cardiac repolarization).Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Puma Biotechnology, Inc.Treatments:
Fluoroquinolones
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination
Criteria
Inclusion Criteria:- Men or women of nonchildbearing potential,
- 18-50 years old.
- Healthy as determined by the investigator, including physical examination, laboratory
test results, and medical history.